[go: up one dir, main page]

GB202406311D0 - Method - Google Patents

Method

Info

Publication number
GB202406311D0
GB202406311D0 GBGB2406311.7A GB202406311A GB202406311D0 GB 202406311 D0 GB202406311 D0 GB 202406311D0 GB 202406311 A GB202406311 A GB 202406311A GB 202406311 D0 GB202406311 D0 GB 202406311D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2406311.7A
Other versions
GB2629917A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sania Rx Ltd
Original Assignee
Sania Rx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sania Rx Ltd filed Critical Sania Rx Ltd
Publication of GB202406311D0 publication Critical patent/GB202406311D0/en
Publication of GB2629917A publication Critical patent/GB2629917A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14111Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB2406311.7A 2023-05-10 2024-05-07 Method Pending GB2629917A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2306914.9A GB202306914D0 (en) 2023-05-10 2023-05-10 Method

Publications (2)

Publication Number Publication Date
GB202406311D0 true GB202406311D0 (en) 2024-06-19
GB2629917A GB2629917A (en) 2024-11-13

Family

ID=86763316

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB2306914.9A Ceased GB202306914D0 (en) 2023-05-10 2023-05-10 Method
GB2406311.7A Pending GB2629917A (en) 2023-05-10 2024-05-07 Method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB2306914.9A Ceased GB202306914D0 (en) 2023-05-10 2023-05-10 Method

Country Status (6)

Country Link
CN (1) CN121420066A (en)
AU (1) AU2024269308A1 (en)
CO (1) CO2025017034A2 (en)
GB (2) GB202306914D0 (en)
IL (1) IL324455A (en)
WO (1) WO2024231830A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
JP5763758B2 (en) * 2010-07-08 2015-08-12 ファイザー・インク Piperidinyl pyrimidineamide as a Kv7 potassium channel opener
WO2021119018A1 (en) * 2019-12-09 2021-06-17 The Board Of Trustees Of The Leland Stanford Junior University A method to improve sleep quality in the elderly by controlling excitability of hypocretin neurons

Also Published As

Publication number Publication date
GB2629917A (en) 2024-11-13
AU2024269308A1 (en) 2025-11-20
CO2025017034A2 (en) 2025-12-19
GB202306914D0 (en) 2023-06-21
WO2024231830A1 (en) 2024-11-14
IL324455A (en) 2026-01-01
CN121420066A (en) 2026-01-27

Similar Documents

Publication Publication Date Title
GB202207026D0 (en) Method
GB202216162D0 (en) Method
GB202214328D0 (en) Method
GB202213924D0 (en) Method
GB202209640D0 (en) Method
GB202406311D0 (en) Method
GB202304744D0 (en) Method
GB202304439D0 (en) Method
GB202304298D0 (en) Method
GB202303653D0 (en) Method
GB202303637D0 (en) Method
GB202302947D0 (en) Method
GB202302144D0 (en) Method
GB202301247D0 (en) Method
GB202301032D0 (en) Method
GB202300905D0 (en) Method
GB202300841D0 (en) Method
GB202219102D0 (en) Method
GB202218893D0 (en) Method
GB202218052D0 (en) Method
GB202217510D0 (en) Method
GB202217506D0 (en) Method
GB202217313D0 (en) Method
GB202217032D0 (en) Method
GB202216610D0 (en) Method